While racial and ethnic diversity in clinical trial participation has long been an issue, COVID-19 vaccine trials have brought this issue to national attention. How can the research community address the root causes for lack of diversity? What actions can be taken to build trust among socioeconomically, racially, and ethnically diverse populations and initiate change? What role do community healthcare centers play in establishing that trust?

Join us for a panel discussion of ways we can unlock the inherent trust between patients and community healthcare providers to encourage diverse representation in clinical trials. Experts from research organizations and community health centers discusses ways biopharma and health centers can come together to improve equity in research.

• Identify ways to overcome root causes of research inequity and increasing diverse enrollment in clinical trials
• Discuss the role of community health centers and how they may be the “missing link” in helping ensure new therapies are safe and effective for the entire US population
• Analyze data that impact negative perceptions regarding research participation and how it could influence decision making for initiatives that drive change
• Describe actions that can be taken across the research ecosystem, including protocol design, trial modalities and use of technology, community engagement, and more

• Presenters

Michelle Russell-Einhorn

JD

Former Chief Compliance Officer and Institutional Official, Advarra

Jonathan Jackson

PhD

Director of the Community Access, Recruitment, & Engagement Research Center, Massachusetts General Hospital; Harvard Medical School

Rajan Sonik

PhD, JD, MPH

Director of Research, AltaMed Health Services

Melissa Opraseuth

PharmD

Chief Operating Officer, par8o